Robotic multichannel pipette device portions out blue fluid for medical and pharmaceutical research and testing.
Image Credits:David B. Gray (opens in a new window) / Getty Images

Verily is closing its medical device program as Alphabet shifts more resources to AI

Alphabet’s life sciences arm Verily laid off staff and eliminated its entire devices program Monday.

CEO Stephen Gillett announced the “difficult decision” to wind down the program in a staff memo, according to Business Insider.

“Over the years, Verily has built a legacy in developing world-class, innovative medical devices,” Gillett wrote, noting that the “path forward requires difficult decisions” as Verily refocuses on AI and data infrastructure.

The move continues Alphabet’s aggressive efforts to invest in AI while cutting costs elsewhere. The company has conducted multiple rounds of layoffs in recent years, including cuts to its HR and cloud units in February and voluntary exit programs for its more than 25,000 Platforms & Devices employees in spring.

Alphabet’s biggest recent layoffs came in January 2023, when it slashed 12,000 jobs — 6% of its workforce at the time — in anticipation of an economic slowdown.

That same month, ChatGPT became the fastest-growing consumer software application in history, gaining over 100 million users in two months and kicking off the generative AI boom that today drives the tech industry’s priorities.

Techcrunch event

Join 10k+ tech and VC leaders for growth and connections at Disrupt 2025

Netflix, Box, a16z, ElevenLabs, Wayve, Hugging Face, Elad Gil, Vinod Khosla — just some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch, and a chance to learn from the top voices in tech. Grab your ticket before doors open to save up to $444.

Join 10k+ tech and VC leaders for growth and connections at Disrupt 2025

Netflix, Box, a16z, ElevenLabs, Wayve, Hugging Face, Elad Gil, Vinod Khosla — just some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss a chance to learn from the top voices in tech. Grab your ticket before doors open to save up to $444.

San Francisco | October 27-29, 2025

Topics

, , , ,

Latest in Biotech & Health